March 2018

In partnership with Nova Southeastern University, Ambrosia will conduct a study on Gabapentin, a controversial medication used in addiction treatment. For the first time, a groundbreaking new study is going to be conducted at a national treatment center. Ambrosia Treatment Center announced this month that they have been selected by Nova Southeastern University to participate […]

Ambrosia Announces 19k Square-Foot Expansion in South New Jersey

Company News / Danesh Alam MD, DFAPA, DFASAM

Ambrosia Announces 19k Square-Foot Expansion in South New Jersey Read More »

Press Release: Ambrosia Treatment Center has completed construction of a new center, an expansion of their existing Southern New Jersey Campus. The project adds more quality addiction treatment in the Greater Philadelphia area in response to the growing epidemic in the Northeast. This spring, Ambrosia Treatment Center will expand its Medford, New Jersey campus with a

Ambrosia Releases 2018 Corporate Social Responsibility Report

Company News / Danesh Alam MD, DFAPA, DFASAM

Ambrosia Releases 2018 Corporate Social Responsibility Report Read More »

Ambrosia is dedicated to providing great treatment, but it doesn’t stop there. Read Ambrosia’s 2018 Corporate Social Responsibility Report to find out how we’re making a positive impact.